| Quantity | 1Set | 100mg, 5mg, 2mg, 1mg, 25mg | 250µl, 1ml, 500µl | 100mg, 5mg, 50mg, 10mg, 25mg | 25g |
| Description | FCGR2A Human Pre-designed siRNA Set A contains three designed siRNAs for FCGR2A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components FCGR2A siRNA-1: 5 nmol (HPLC) FCGR2A siRNA-2: 5 nmol (HPLC) FCGR2A siRNA-3: 5 nmol (HPLC) siRNA Negative FCGR2A Human Pre-designed siRNA Set A contains three designed siRNAs for FCGR2A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components FCGR2A siRNA-1: 5 nmol (HPLC) FCGR2A siRNA-2: 5 nmol (HPLC) FCGR2A siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | Amyloid β-Protein Fragment 25-35 (Aβ25-35) is derived from the amyloid-β protein.amyloid-β protein, which is mapped to human chromosome 21q21.Aβ25-35 lacks the N-terminal domain and the metal binding site and is majorly generated by proteolytic cleavage of Aβ(1−40Amyloid β-Protein Fragment 25-35 (Aβ25-35) is derived from the amyloid-β protein.amyloid-β protein, which is mapped to human chromosome 21q21.Aβ25-35 lacks the N-terminal domain and the metal binding site and is majorly generated by proteolytic cleavage of Aβ(1−40) peptides. It has a β-sheet and β-turn structure. Amino Acid Sequence Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-MetFunctional domain of Aβ required for both neurotrophic and neurotoxic effects... Read More | The content of this cell is too long for an XLSX file (more than 32767 characters). Please use the CSV format for this export | IRE1α kinase-IN-2 is a potent IRE1α kinase inhibitor, with an EC 50 of 0.82 µM. IRE1α kinase-IN-2 inhibits IRE1α kinase autophosphorylation (IC 50 =3.12 µM). IRE1α kinase-IN-2 inhibits XBP1 mRNA splicing in the WT cell lines.In VitroIRE1α kinase-IN-2 (compoundIRE1α kinase-IN-2 is a potent IRE1α kinase inhibitor, with an EC 50 of 0.82 µM. IRE1α kinase-IN-2 inhibits IRE1α kinase autophosphorylation (IC 50 =3.12 µM). IRE1α kinase-IN-2 inhibits XBP1 mRNA splicing in the WT cell lines.In VitroIRE1α kinase-IN-2 (compound 3) inhibits XBP1 mRNA splicing, even during ER stress. MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:Solid... Read More | Crystal phase: anatase/rutile ca. 80:20 |